Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Cerus Corporation

CERSNASDAQ
Healthcare
Medical - Devices
$2.56
$0.00(0.00%)
U.S. Market is Open • 15:29

Cerus Corporation (CERS) Stock Overview

Explore Cerus Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap462.9M
P/E Ratio-28.66
EPS (TTM)$-0.08
ROE-0.28%
Fundamental Analysis

AI Price Forecasts

1 Month$1.85
3 Months$2.58
1 Year Target$1.86

CERS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cerus Corporation (CERS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 54.89, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.86.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -28.66 and a market capitalization of 462.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-5.86%
5-Day Change
9.55%
1-Month Change
-2.82%
3-Month Change
61.74%
6-Month Change
107.76%
Year-to-Date (YTD) Change
22.34%
1-Year Change
38.51%
3-Year Change
-12.68%
5-Year Change
-66.71%
All-Time (Max) Change
-80.12%

Contact Information

925 288 6000
1220 Concord Avenue, Concord, CA, 94520

Company Facts

6,140 Employees
IPO DateJan 31, 1997
CountryUS
Actively Trading

Frequently Asked Questions